CClinicalTrials.gg
CompletedNCT05411328Updated Aug 6, 2024

Efficacy of Virtual Reality on Balance in Children With Ataxic Cerebral Palsy Randomized Controlled Trail

An interventional study of virtual reality in Ataxic Cerebral Palsy, sponsored by Delta University for Science and Technology. Completed at 1 site in Egypt. Open to participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2024-08-06.

Sponsored by Delta University for Science and Technology · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
9 Years to 14 Years
Sex
All
01

Study summary

Ataxic CP is one type of cerebral palsy. children with ataxic cerebral palsy have trouble with balance and coordination. They may walk with their legs farther apart than other kids and have a hard time with activities that use small hand movements, like writing. Some also have trouble with depth perception This means being able to accurately judge how close or far away something is

02

Conditions studied

03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.

This study's enrollment of 64 is above the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Delta University for Science and Technology is the lead sponsor of 82 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ataxic cerebral palsy aged 9-14 years

Exclusion criteria

Exclusion Criteria:

  • any musculoskeletal conditions that affect balance previous surgeries that affecting balance
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (actual)

Study arms

  • Experimental
    traditional physical therapy group

    received traditional physical therapy protocol

    Device: virtual reality

  • Experimental
    virtual reality group

    received the same traditional physical therapy in addition to virtual reality games

    Device: virtual reality

Interventions

  • Devicevirtual reality

    All children in the two groups received physical therapy protocol for 30 minutes in addition to virtual reality game traditional physical therapy group traditional physical therapy group

06

What researchers measure

Primary outcomes

  1. Change in overall stability index

    change in overall stability index will measured by using biodex balance system

    Time frame: [Time Frame: baseline and after 3 months of intervention.]

07

Study locations

1 site
  • Delta University for Science and Technology
    Gamasa, Dakahelia 4030, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05411328
Lead sponsor
Delta University for Science and Technology
Responsible party
walaa eldesoukey heneidy (lecturer of physical therapy, Delta University for Science and Technology) — Principal investigator
First posted
Jun 9, 2022
Start date
Nov 1, 2022
Primary completion
Apr 15, 2024
Completion
Apr 30, 2024
Last update
Aug 6, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion